Attenuated Toxoplasma gondii enhances the antitumor efficacy of anti-PD1 antibody by altering the tumor microenvironment in a pancreatic cancer mouse model

被引：0

作者：

Said Ahmed Bahwal

Jane J. Chen

Lilin E

Taofang Hao

Jiancong Chen

Vern B. Carruthers

Jiaming Lai

Xingwang Zhou

机构：

[1] Sun Yat-Sen University,Department of Biochemistry and Molecular Biology, Sun Yat

[2] Warren Alpert Medical School of Brown University,Sen University Zhongshan School of Medicine

[3] Sun Yat-Sen University,Department of Pancreato

[4] University of Michigan School of Medicine,Biliary Surgery, The First Affiliated Hospital

来源：

Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷

关键词：

Dendritic cells; Immunotherapy; Programmed cell death 1 receptor; Vaccination;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：2743 / 2757

页数：14

共 50 条

[1] Attenuated Toxoplasma gondii enhances the antitumor efficacy of anti-PD1 antibody by altering the tumor microenvironment in a pancreatic cancer mouse model
Bahwal, Said Ahmed
Chen, Jane J.
E, Lilin
Hao, Taofang
Chen, Jiancong
Carruthers, Vern B.
Lai, Jiaming
Zhou, Xingwang
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (10) : 2743 - 2757
[2] Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment
Lang, Julie
Capasso, Anna
Jordan, Kimberly R.
French, Jena D.
Kar, Adwitiya
Bagby, Stacey M.
Barbee, Jacob
Yacob, Betelehem W.
Head, Lia S.
Tompkins, Kenneth D.
Freed, Brian M.
Somerset, Hilary
Clark, Toshimasa J.
Pitts, Todd M.
Messersmith, Wells A.
Eckhardt, S. Gail
Wierman, Margaret E.
Leong, Stephen
Kiseljak-Vassiliades, Katja
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (01): : 26 - 42
[3] Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapse
Guerin, Marion, V
Regnier, Fabienne
Thoreau, Maxime
Vimeux, Lene
Benard, Matthieu
Dransart, Estelle
Penny, Hweixian L.
Johannes, Ludger
Trautmann, Alain
Bercovici, Nadege
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
[4] Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer
Guo, Zhiqiang
Wang, Haolin
Meng, Fandong
Li, Jie
Zhang, Shulan
JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
[5] β-Glucan-conjugated anti-PD-L1 antibody enhances antitumor efficacy in preclinical mouse models
Wang, Qian
Jiang, Hao
Zhang, Hongli
Lu, Weiqiao
Wang, Xiao
Xu, Wenfeng
Li, Jia
Lv, Youjing
Li, Guoyun
Cai, Chao
Yu, Guangli
CARBOHYDRATE POLYMERS, 2024, 324
[6] Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
Highfill, Steven L.
Cui, Yongzhi
Giles, Amber J.
Smith, Jillian P.
Zhang, Hua
Morse, Elizabeth
Kaplan, Rosandra N.
Mackall, Crystal L.
SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (237)
[7] Anti-PD1 antibody and not anti-LAG-3 antibody improves the antitumor effect of photodynamic therapy for treating metastatic breast cancer
Long, Shan
Zhao, Yibing
Xu, Yuanyuan
Wang, Bo
Qiu, Haixia
Zhao, Hongyou
Zeng, Jing
Chen, Defu
Li, Hui
Shao, Jiakang
Li, Xiaosong
Gu, Ying
JOURNAL OF INNOVATIVE OPTICAL HEALTH SCIENCES, 2024, 17 (01)
[8] PAR2 deficiency impairs antitumor immunity and attenuates anti-PD1 efficacy in colorectal cancer
Liu, Zilin
Jiang, Xuehui
Ke, Ziliang
Wang, Weihong
Tang, Jianqiang
Dai, Yun
PHARMACOLOGICAL RESEARCH, 2025, 215
[9] Bifunctional molecular probe targeting tumor PD-L1 enhances anti-tumor efficacy by promoting ferroptosis in lung cancer mouse model
Shao, Chenxu
Yan, Xiaoping
Pang, Shangjie
Nian, Di
Ren, Li
Li, Hui
Sun, Junjie
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 130
[10] Efficacy of trifluridine/tipiracil plus anti-mouse PD-1 antibody combination on mouse colorectal cancer model
Tsukihara, Hiroshi
Kobunai, Takashi
Takechi, Teiji
CANCER SCIENCE, 2018, 109 : 847 - 847

← 1 2 3 4 5 →